Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

Detalles Bibliográficos
Autores principales: Vincent, J, Bernard, G, Dhainaut, J, Janes, J, Wright, T, Gaillez, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099702/
http://dx.doi.org/10.1186/cc2582
Descripción
Sumario:

Ejemplares similares